PD-L1 was significantly associated with shorter 5-year OS regardless of sex, age, tumor size, histology, location, surgical outcome, and adjuvant treatment, implying that PD-L1 is an independent negative prognostic factor in sarcoma. The gene discussed is CD274; the disease is neoplasm.